Filter
1666
Filtered Results: 1666
Text search:
assays
Featured
Recommendations
218
New Publications
426
Language
Document type
No document type
871
Guidelines
356
Studies & Reports
223
Manuals
87
Fact sheets
48
Strategic & Response Plan
47
Training Material
17
Situation Updates
8
Resource Platforms
5
Infographics
2
Brochures
1
Online Courses
1
Countries / Regions
India
102
Global
53
Western and Central Europe
46
South Africa
35
Tanzania
28
Germany
26
Eastern Europe
26
Latin America and the Carribbean
24
Kenya
22
Nigeria
22
Brazil
22
Nepal
21
Africa
20
Ethiopia
20
Uganda
19
Russia
18
Sierra Leone
17
Syria
17
Malawi
17
Ukraine
16
Zambia
16
Liberia
16
Congo, Democratic Republic of
15
Myanmar / Burma
15
Ghana
14
Mozambique
14
Colombia
13
Rwanda
13
Bangladesh
13
Namibia
12
West and Central Africa
10
Haiti
9
Middle East and North Africa
9
East and Southern Africa
9
Argentina
9
Philippines
8
Venezuela
8
South–East Asia Region
8
Lesotho
7
Senegal
7
Zimbabwe
7
Cambodia
7
Asia
7
Central African Republic
7
Burkina Faso
6
Eastern Europe and Central Asia
6
Indonesia
6
Madagascar
6
Benin
5
Cameroon
5
Peru
5
Yemen
5
Angola
5
El Salvador
4
Chile
4
USA
4
Mali
4
Somalia
4
Eswatini/ Swaziland
4
Mexico
3
Niger
3
Afghanistan
3
Jordan
3
Saudi Arabia
3
Western Pacific Region
3
Paraguay
3
Bolivia
3
Lebanon
3
Sri Lanka
3
Sudan
3
Libya
3
Botswana
3
Ecuador
3
Pakistan
3
Timor Leste/ East Timor
2
China
2
Iran
2
Qatar
2
Guinea
2
Armenia
2
Dominican Republic
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Moldova
2
Egypt
2
Palestine
2
Georgia
2
Chad
2
Bhutan
2
Iraq
2
North Macedonia
1
Tajikistan
1
North Korea
1
Switzerland
1
Turkey
1
Kazakhstan
1
Albania
1
Estonia
1
Congo-Brazzaville
1
Morocco
1
Mongolia
1
Mauritania
1
Guinea-Bissau
1
North America
1
Uruguay
1
Jamaica
1
France
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Southern Africa
1
Vietnam
1
Papua New Guinea
1
Nicaragua
1
Djibouti
1
Romania
1
Honduras
1
South Sudan
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
561
Clinical Guidelines
241
Pharmacy & Technologies
70
Public Health
60
Key Resources
34
Women & Child Health
26
Capacity Building
9
Toolboxes
TB
322
HIV
185
COVID-19
182
NTDs
145
Ebola & Marburg
51
Rapid Response
49
AMR
32
Zika
31
Refugee
30
Malaria
30
Pharmacy
29
Conflict
26
Mental Health
25
NCDs
22
2.0 Rapid Response
18
Planetary Health
15
Polio
13
Natural Hazards
9
Caregiver
9
Specific Hazards
8
Cholera
4
Health Financing Toolbox
4
Disability
2
Global Health Education
2
Testing Guidance and Interpretation of Results for Healthcare Providers
Zika Virus Testing Guidance: Asymptomatic Pregnant Women
with Possible Zika Virus Exposure
The aim of the meeting was to broaden the network’s initiatives. Preliminary work involved integrating laboratory testing for skin NTDs other than Buruli ulcer, such as cutaneous leishmaniasis, mycetoma, leprosy and yaws, while extending the network’s reach to encompass additional laboratories.
WHO list of priority medical devices for management of cardiovascular diseases and diabetes
recommended
This publication was developed in response to the need for a reference list of priority medical devices required for management of noncommunicable diseases (NCDs), focusing on cardiovascular diseases and diabetes, especially for low- and middle-income countries to support universal health coverage a...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin...
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long
been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still
kills about 60 000 people a year, of whom over 40% are children under 15, mainly in rural areas
of economically ...
C’est dans ce contexte particulièrement complexe qu’ONU Femmes et CARE, sous le leadership du Ministère à la Condition féminine et aux Droits des femmes (MCFDF) et en coordination avec la Direction Générale de la Protection Civile (DGPC), ont lancé l’Analyse Rapide Genre qui se veut une...
This paper introduces a new dataset of official financing—including foreign aid and other forms of concessional and non-concessional state financing—from China to 138 countries between 2000 and 2014. We use these data to investigate whether and to what extent Chinese aid affects economic growth ...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information...
mBio, Vol. 6 Issue 2, March/April 2015
Available evidence demonstrates that direct patient contact and contact with infectious body fluids are the primary modes for Ebola virus transmission, but this is based on a limited number of studies. In this review, the authors address what we know and what ...
Conceived as part of the CWS-A/P project on regional security and risk management, this book presents a
collection of testimonies from aid workers in some of the most insecure and volatile environments in the world.
The participants recount a broad array of security incidents, such as kidnappings,...
Key populations brief
Accessed November 2017
L’ampleur de la résistance aux insecticides chez les vecteurs du paludisme met en péril l’efficacité des programmes de lutte anti-vectorielle. Si cette résistance n’est pas atténuée, le taux de morbidité palustre va s’accroître, entraînant une hausse significative des coûts liés ...
Int J Crit Illn Inj Sci. 2012 May-Aug; 2(2): 82–97.
doi: 10.4103/2229-5151.97273
PMCID: PMC3401822
PMID: 22837896
